To test this, we performed RNA-seq and genome-wide DNA methylation analysis using Illumina’s Infinium arrays to determine the effect of silencing of KRAS in the 11 KRAS-mutant and -dependent pancreatic cancer cells. Here, KRAS is linked to familial pancreatic carcinoma.